INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,529
88 sh
Jan 30, 2026Jan 30, 2026
Page 1368 of 1786
← PrevNext →
traded Jan 30, 2026
+0d
SEC Form 4

Evidence

27
SI
Stefan Constantin IonelChief Technology Officer
AMPXAmprius Technologies, Inc.
Open-market sale
SELL$476K
39.7K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

27
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$394K
21.3K sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

26
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Grant or award
A$1.25M
19.2K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
SE
Sindicich Michael EricPresident
NAVNNavan, Inc.
Open-market sale
SELL$3,760
268 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
GM
Giviskos Anne MaryInterim CFO
NAVNNavan, Inc.
Open-market sale
SELL$1,063
77 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$227K
2,188 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$164K
1,496 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$69K
616 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$147K
1,421 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
472 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$209K
1,931 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
669 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
GM
Giviskos Anne MaryInterim CFO
NAVNNavan, Inc.
Open-market sale
SELL$36K
2,598 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

26
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$97K
905 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

25
MP
McGough PatrickVice President of Operations
CRKCOMSTOCK RESOURCES INC
Grant or award
A$306K
13.6K sh
Jan 27, 2026Jan 30, 2026
traded Jan 27, 2026
+3dSEC Form 4

Evidence

25
CM
Curet MyriamEVP & Chief Medical Officer
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$66K
126 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

25
CC
Claunch Brian ChristopherVP of Financial Reporting
CRKCOMSTOCK RESOURCES INC
Grant or award
A$280K
12.5K sh
Jan 27, 2026Jan 30, 2026
traded Jan 27, 2026
+3dSEC Form 4

Evidence

25
GJ
Gahlhoff Jerry Jr.Director, PRESIDENT & CEO
ROLROLLINS INC
Open-market sale
SELL$82K
1,307 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

24
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$39K
3,869 sh
Jan 6, 2026Jan 30, 2026
traded Jan 6, 2026
+24dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Sep 3, 2024Jan 30, 2026
traded Sep 3, 2024
+514dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
24 sh
Jun 2, 2025Jan 30, 2026
traded Jun 2, 2025
+242dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Dec 2, 2024Jan 30, 2026
traded Dec 2, 2024
+424dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Sep 2, 2025Jan 30, 2026
traded Sep 2, 2025
+150dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Sep 3, 2024Jan 30, 2026
traded Sep 3, 2024
+514dSEC Form 4

Evidence

24
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$109K
5,860 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Mar 3, 2025Jan 30, 2026
traded Mar 3, 2025
+333dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Dec 2, 2024Jan 30, 2026
traded Dec 2, 2024
+424dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Sep 2, 2025Jan 30, 2026
traded Sep 2, 2025
+150dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Dec 1, 2025Jan 30, 2026
traded Dec 1, 2025
+60dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Dec 1, 2025Jan 30, 2026
traded Dec 1, 2025
+60dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
24 sh
Jun 2, 2025Jan 30, 2026
traded Jun 2, 2025
+242dSEC Form 4

Evidence

24
MP
Mack Robert PaulCFO, EVP - Finance + Corp Dev
PIIPolaris Inc.
Option exercise
M—
23 sh
Mar 3, 2025Jan 30, 2026
traded Mar 3, 2025
+333dSEC Form 4

Evidence

23
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
197 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

23
LN
Lantz Erin NChief Revenue Officer
LIFEEthos Technologies Inc.
Option exercise
M$254K
85.2K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

22
TD
Tesh Thomas DChief Admin. Officer
ROLROLLINS INC
Open-market sale
SELL$20K
323 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

22
ME
Mills Ronald EugeneVP of Finance. and IR
CRKCOMSTOCK RESOURCES INC
Grant or award
A$239K
10.6K sh
Jan 27, 2026Jan 30, 2026
traded Jan 27, 2026
+3dSEC Form 4

Evidence

21
HC
Holmes Rob CChairman, President and CEO
TCBITEXAS CAPITAL BANCSHARES INC/TX
Option exercise
M—
9,200 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

21
MC
Malenka Robert C.Director
MPLTMapLight Therapeutics, Inc.
Open-market sale
SELL$13K
664 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

21
CW
Cummings John WChief Administrative Officer
TCBITEXAS CAPITAL BANCSHARES INC/TX
Option exercise
M—
1,499 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence